About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
19 11, 2025

DOGE holds $0.15 amid OI stability

By |2025-11-19T16:03:06+02:00November 19, 2025|Crypto News, News|0 Comments

Dogecoin (DOGE) is extending its decline, trading at around $0.1587 at the time of writing on Wednesday. Since the October 10 flash crash, which liquidated over $19 billion in crypto assets in a single day, the leading meme coin with a market capitalisation of $24 billion has lost 37% of its value. 

The steady sell-off reflects bearish sentiment in the broader cryptocurrency market, driven by uncertainty ahead of the next Federal Reserve (Fed) monetary policy meeting in December and a lack of significant price catalysts in the crypto space.

Fed Chair Jerome Powell said during the October policy meeting that a December rate cut was not guaranteed, which spooked investors and fueled risk-off sentiment.

An analysis of Dogecoin’s derivatives market could provide insight into the next direction the meme coin may take, especially as futures Open Interest (OI) stabilizes.

Assessing Dogecoin’s bullish potential 

Dogecoin’s derivatives market is stabilizing, supported by futures OI rising to $1.66 billion on Wednesday. Following the massive deleveraging on October 10, DOGE’s OI dropped to $1.37 billion on November 7, highlighting a sticky risk-off.

Since OI represents the notional value of outstanding futures contracts, a steady increase suggests that investor interest in DOGE is growing. Traders are slowly regaining confidence in Dogecoin’s ability to sustain short-term recovery. As investors increase their risk exposure, the tail force on DOGE intensifies, increasing the probability of a steady recovery.

Dogecoin Open Interest | Source: CoinGlass

Dogecoin OI-Weighted Funding Rate has risen to 0.0076% on Wednesday from Tuesday’s -0.0083% , as traders increasingly pile into long positions. The meme coin must hold onto short-term gains above the $0.1500 support to steady this risk appetite. Otherwise, any sign of weakness may reinforce the bearish outlook.

Dogecoin OI-Weighted Funding Rate | Source: CoinGlass

Technical outlook: Dogecoin vulnerable amid bearish signals

Dogecoin’s recovery remains a pipe dream despite its derivatives market showing signs of stability. The Relative Strength Index (RSI) on the daily chart at 39 risks extending its decline toward oversold territory, potentially escalating the downtrend below $0.1500.

Dogecoin also sits below the 50-day Exponential Moving Average (EMA) at $0.1893, the 100-day EMA at $0.2024, and the 200-day EMA at $0.2090, all of which point to a weak technical structure.

The Money Flow Index (MFI) indicator holds below a descending trendline on the same daily chart, suggesting that money is flowing out of DOGE, which would make recovery an uphill task.

DOGE/USDT daily chart

A break below the immediate support at $0.1500 could push Dogecoin toward $0.1424, a level tested in June. Still, a recovery could occur from the current level if investors increase exposure, supported by a relatively stable derivatives market.

Open Interest, funding rate FAQs

Source link

19 11, 2025

XAU/USD rallies beyond $4,100 on risk-off trading

By |2025-11-19T14:35:30+02:00November 19, 2025|Forex News, News|0 Comments


Gold (XAU/USD) is trading higher for the second consecutive day on Wednesday, reaching intra-week highs, right above $4,100, favoured by the risk-averse markets and heightened hopes that the US Federal Reserve might ease monetary policy at its December meeting.

US employment data disappointed on Tuesday, with Initial Jobless Claims growing and the ADP Weekly Employment Change showing that businesses kept laying off workers in the four weeks to November 1. These figures add pressure on the Federal Reserve to cut interest rates further, although the market is likely to wait for Thursday’s Nonfarm payrolls figures to confirm those views.

Technical Analysis: Potential trend shift for Gold

XAU/USD 4-Hour Chart

Gold has bounced from the 78.6% Fibonacci retracement of the early November rally, near $4,000, and is now eroding resistance at $4,105 (November 17 high). The 4-Hour Relative Strength Index (RSI) has bounced up from the 50 level, and the Moving Average Convergence Divergence is about to cross above the signal line, which suggests that the correction from $4,145 highs might have completed.

To the upside, if the pair manages to hold above the $4,100 area, bulls might gain confidence to test a previous support level at $4.150 (November 13 low) ahead of the November 14 high, at $4,210, and the monthly high, at the mentioned $4,245 level.

A bearish reaction from current levels, on the contrary, is likely to be challenged at the session lows of $4,055 ahead of Tuesday’s low, at the $4,000 level. Further down, the November 4 low, in the area of $3,930, would come into focus.

Gold FAQs

Gold has played a key role in human’s history as it has been widely used as a store of value and medium of exchange. Currently, apart from its shine and usage for jewelry, the precious metal is widely seen as a safe-haven asset, meaning that it is considered a good investment during turbulent times. Gold is also widely seen as a hedge against inflation and against depreciating currencies as it doesn’t rely on any specific issuer or government.

Central banks are the biggest Gold holders. In their aim to support their currencies in turbulent times, central banks tend to diversify their reserves and buy Gold to improve the perceived strength of the economy and the currency. High Gold reserves can be a source of trust for a country’s solvency. Central banks added 1,136 tonnes of Gold worth around $70 billion to their reserves in 2022, according to data from the World Gold Council. This is the highest yearly purchase since records began. Central banks from emerging economies such as China, India and Turkey are quickly increasing their Gold reserves.

Gold has an inverse correlation with the US Dollar and US Treasuries, which are both major reserve and safe-haven assets. When the Dollar depreciates, Gold tends to rise, enabling investors and central banks to diversify their assets in turbulent times. Gold is also inversely correlated with risk assets. A rally in the stock market tends to weaken Gold price, while sell-offs in riskier markets tend to favor the precious metal.

The price can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can quickly make Gold price escalate due to its safe-haven status. As a yield-less asset, Gold tends to rise with lower interest rates, while higher cost of money usually weighs down on the yellow metal. Still, most moves depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAU/USD). A strong Dollar tends to keep the price of Gold controlled, whereas a weaker Dollar is likely to push Gold prices up.



Source link

19 11, 2025

EUR/GBP Forecast Today 19/11: Holds Key Support (Video)

By |2025-11-19T14:20:35+02:00November 19, 2025|Forex News, News|0 Comments

  • EUR/GBP shows early attempts to rally but continues to struggle for sustained traction.
  • Support near 0.8750 remains crucial, backed by prior resistance, recent tests, and the 50-day EMA.
  • Broader bias still favors upside toward 0.89.

The Euro initially tried to rally a bit during the trading session here on Tuesday, but then gave back the gains as the Euro continues to struggle with traction. All things being equal, this is a market that I think eventually will try to find some support, and there is a very obvious place to look.

0.8750 Continues to Matter

That is the 0.8750 level. That’s an area that previously had been resistant, so it’s worth looking at it through the prism of market memory. It has been tested a couple of times here in the last couple of weeks, and it has held quite nicely. We now see the 50-day EMA race toward it as well, so that’s another reason to think that this could offer some support.

But with that, we will have to wait and see. The fact that we could not hang on to gains for the second or third day in a row really suggests a scenario where a little bit of a breather helps and offers enough value that people are willing to get involved in the market and start buying. In general, I do believe this is a market that will continue to be somewhat noisy, but it’s also a market that still favors the upside as, although the Bank of England did not cut rates at the last meeting, they are getting very close to doing so, and that of course, means that we have to reprice the British pound itself.

Over the longer term, the 0.89 level is more likely than not to be your target based on the consolidation area that we just broke out of and its measured move. I have no interest in shorting this pair anytime soon.

Ready to trade our daily Forex analysis? We’ve made this forex brokers list for you to check out.

Christopher Lewis has been trading Forex and has over 20 years experience in financial markets. Chris has been a regular contributor to Daily Forex since the early days of the site. He writes about Forex for several online publications, including FX Empire, Investing.com, and his own site, aptly named The Trader Guy. Chris favours technical analysis methods to identify his trades and likes to trade equity indices and commodities as well as Forex. He favours a longer-term trading style, and his trades often last for days or weeks.

Source link

19 11, 2025

Appetite Suppressants Market Massive Growth opportunity Ahead

By |2025-11-19T14:05:30+02:00November 19, 2025|Dietary Supplements News, News|0 Comments


Appetite Suppressants Market

HTF MI just released the Global Appetite Suppressants Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study’s segmentation by important regions. The market is currently expanding its reach.

Major Giants in Appetite Suppressants Market are:

GSK (GlaxoSmithKline) (UK), Novo Nordisk (Denmark), Roche (Switzerland), Eli Lilly and Company (USA), Amgen Inc. (USA), Pfizer Inc. (USA), Hoffmann-La Roche AG (Switzerland), Bristol-Myers Squibb (USA), AbbVie Inc. (USA), Herbalife Nutrition Ltd. (USA), Nutrisystem, Inc. (USA)

Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)👉 https://www.htfmarketintelligence.com/sample-report/global-appetite-suppressants-market?utm_source=Alefiya_OpenPR&utm_id=Alefiya

HTF Market Intelligence projects that the global Appetite Suppressants market will expand at a CAGR of 8.5% from 2025 to 2032, from USD 4.5 Billion in 2025 to USD 8 Billion by 2032.

Our Report Covers the Following Important Topics:

By Type:

Pharmaceutical Appetite Suppressants, Dietary Supplements, Natural Appetite Suppressants

By Application:

Weight Loss Management, Fitness and Bodybuilding, Health and Wellness

The Appetite Suppressants Market refers to the global industry focused on products, supplements, and pharmaceutical drugs designed to reduce hunger, control cravings, and support weight management. These suppressants work by influencing appetite-regulating hormones, altering neurotransmitter activity, or creating a feeling of fullness. They are available in prescription medications, over-the-counter (OTC) products, herbal supplements, and functional foods/beverages.

Market Trends:

• Increasing use of digital health tools and apps integrated with weight-loss products.

• Growing demand for personalized nutrition and supplements tailored to individual metabolism.

Market Drivers:

• Increasing global prevalence of obesity, diabetes, and lifestyle-related disorders.

• Rising health and fitness awareness among consumers.

• Strong demand from weight management programs, gyms, and wellness centers.

Market Opportunities:

• Development of AI-powered personalized appetite suppressant solutions.

• High growth potential in emerging markets with rising obesity rates.

• Expansion of nutraceutical and herbal product portfolios for weight control.

Have a query? Ask Our Expert 👉 👉 https://www.htfmarketintelligence.com/enquiry-before-buy/global-appetite-suppressants-market?utm_source=Alefiya_OpenPR&utm_id=Alefiya

The titled segments and sub-section of the market are illuminated below:

In-depth analysis of Appetite Suppressants market segments by Types: Pharmaceutical Appetite Suppressants, Dietary Supplements, Natural Appetite Suppressants

Detailed analysis of Appetite Suppressants market segments by Applications: Weight Loss Management, Fitness and Bodybuilding, Health and Wellness

Global Appetite Suppressants Market -Regional Analysis

• North America: United States of America (US), Canada, and Mexico.

• South & Central America: Argentina, Chile, Colombia, and Brazil.

• Middle East & Africa: Kingdom of Saudi Arabia, United Arab Emirates, Turkey, Israel, Egypt, and South Africa.

• Europe: the UK, France, Italy, Germany, Spain, Nordics, BALTIC Countries, Russia, Austria, and the Rest of Europe.

• Asia: India, China, Japan, South Korea, Taiwan, Southeast Asia (Singapore, Thailand, Malaysia, Indonesia, Philippines & Vietnam, etc.) & Rest

• Oceania: Australia & New Zealand

Buy Now Latest Edition of Appetite Suppressants Market Report 👉 https://www.htfmarketintelligence.com/book-now?format=1&report=17115?utm_source=Alefiya_OpenPR&utm_id=Alefiya

Appetite Suppressants Market Research Objectives:

– Focuses on the key manufacturers, to define, pronounce and examine the value, sales volume, market share, market competition landscape, SWOT analysis, and development plans in the next few years.

– To share comprehensive information about the key factors influencing the growth of the market (opportunities, drivers, growth potential, industry-specific challenges and risks).

– To analyze the with respect to individual future prospects, growth trends and their involvement to the total market.

– To analyze reasonable developments such as agreements, expansions new product launches, and acquisitions in the market.

– To deliberately profile the key players and systematically examine their growth strategies.

FIVE FORCES & PESTLE ANALYSIS:

Five forces analysis-the threat of new entrants, the threat of substitutes, the threat of competition, and the bargaining power of suppliers and buyers-are carried out to better understand market circumstances.

• Political (Political policy and stability as well as trade, fiscal, and taxation policies)

• Economical (Interest rates, employment or unemployment rates, raw material costs, and foreign exchange rates)

• Social (Changing family demographics, education levels, cultural trends, attitude changes, and changes in lifestyles)

• Technological (Changes in digital or mobile technology, automation, research, and development)

• Legal (Employment legislation, consumer law, health, and safety, international as well as trade regulation and restrictions)

• Environmental (Climate, recycling procedures, carbon footprint, waste disposal, and sustainability)

Get 10-25% Discount on Immediate purchase 👉 https://www.htfmarketintelligence.com/request-discount/global-appetite-suppressants-market?utm_source=Alefiya_OpenPR&utm_id=Alefiya

Points Covered in Table of Content of Global Appetite Suppressants Market:

Chapter 01 – Appetite Suppressants Market Executive Summary

Chapter 02 – Market Overview

Chapter 03 – Key Success Factors

Chapter 04 – Global Appetite Suppressants Market – Pricing Analysis

Chapter 05 – Global Appetite Suppressants Market Background or History

Chapter 06 – Global Appetite Suppressants Market Segmentation (e.g. Type, Application)

Chapter 07 – Key and Emerging Countries Analysis Worldwide Appetite Suppressants Market

Chapter 08 – Global Appetite Suppressants Market Structure & worth Analysis

Chapter 09 – Global Appetite Suppressants Market Competitive Analysis & Challenges

Chapter 10 – Assumptions and Acronyms

Chapter 11 – Appetite Suppressants Market Research Method Appetite Suppressants

Thank you for reading this post. You may also obtain report versions by area, such as North America, LATAM, Europe, Japan, Australia, or Southeast Asia, or by chapter.

Contact Us:

Nidhi Bhavsar (PR & Marketing Manager)

HTF Market Intelligence Consulting Private Limited

Phone: +15075562445

sales@htfmarketintelligence.com

About Author:

HTF Market Intelligence Consulting is uniquely positioned to empower and inspire with research and consulting services to empower businesses with growth strategies, by offering services with extraordinary depth and breadth of thought leadership, research, tools, events, and experience that assist in decision-making.

This release was published on openPR.



Source link

19 11, 2025

ADA Fails to Clear $1 While Bitcoin

By |2025-11-19T14:00:28+02:00November 19, 2025|Crypto News, News|0 Comments

Cardano Price Prediction

Cardano price prediction talk is heating up again as ADA pushes toward the $1 zone. The hype that used to pump Cardano headlines has cooled off, and traders are starting to play it safer. A lot of people are now scanning the market for the next big crypto, something faster, fresher, and offering better payout potential. That spotlight is shifting toward Bitcoin Hyper (https://bitcoinhyper.com/), a high-speed, payments-focused project built for real utility with low fees and instant style transfers. It blends strong tech with meme-level momentum, which is why more ADA holders are giving it a serious look. Here is where ADA stands right now and why Bitcoin Hyper is pulling in more attention going into 2025.

Cardano Price Outlook: Will ADA Finally Break the $1 Barrier?

The price of Cardano (ADA) is back under the spotlight as it flirts with the $1 threshold. ADA is currently trading around $0.46, remaining firmly below the mark as buying interest falters and resistance remains entrenched. Technical indicators reflect the hesitation. The RSI hovers near 50, signaling a lack of conviction among traders. Meanwhile, ADA is still down over 80% from its all-time high, even after multiple minor rebounds. Market sentiment appears to be shifting. The buzz around Cardano updates and ecosystem developments has cooled, and some traders are now looking beyond ADA for higher speed and higher reward opportunities. That attention is turning to Bitcoin Hyper (HYPER), a project promising fast throughput, low fees, and strong upside potential. If ADA cannot clear $1 soon, this could accelerate capital rotation into newer targets such as Bitcoin Hyper, especially among holders seeking fresh narratives and higher momentum.

Bitcoin Hyper: Fast payments, powerful staking and a next generation Bitcoin layer 2 vision

Bitcoin Hyper (https://bitcoinhyper.com/) is a next-generation Bitcoin layer 2 project built for speed, cheap transactions, and real staking rewards. Unlike traditional meme tokens or slow legacy chains, it offers a high reward system for early adopters and a utility-driven ecosystem designed to power the next wave of Bitcoin-based applications. Early participants get significantly higher staking yields that gradually reduce as more users join, giving first movers a real advantage. Transfers on Bitcoin Hyper are nearly instant and cost a fraction of Bitcoin layer 1 fees, making HYPER a fast and efficient option for traders. The presale has already crossed more than $27M raised, showing strong traction among investors.

Users can buy and stake HYPER directly during the presale, with high-yield reward tiers offering exceptional incentives. The project also plans to roll out gamified staking, NFTs, and cross-chain integrations as the ecosystem expands.

Bitcoin Hyper rewards investors with speed, staking, and utility

Bitcoin Hyper keeps its community active with real use incentives and high throughput performance. Traders who follow Cardano news and ADA price updates are noticing the contrast. While ADA focuses on long term gradual upgrades, Bitcoin Hyper delivers instant rewards, rapid confirmation times, and far lower costs. Its high reward staking system offers extremely strong APY levels for early HYPER holders. Rewards scale down over time as more participants join, keeping the system balanced.

For presale investors, Bitcoin Hyper (https://bitcoinhyper.com/) combines fast payments, high rewards, and a functional layer 2 foundation in one ecosystem. Early adopters can stake, trade, and access high yield opportunities on a chain built for real utility. This is not just another meme coin, Bitcoin Hyper provides speed, staking, and a complete framework for one of the strongest crypto presale opportunities in the current market. Even long time ADA holders are watching how HYPER stacks up against older alt coins as momentum shifts toward faster and more rewarding projects.

Conclusion

The latest Cardano price outlook shows ADA still stuck below $1, and that slowdown is pushing traders to scout faster and more rewarding plays. Bitcoin Hyper is getting that attention with its high-speed layer 2 design, low fees, and a presale that keeps gaining traction. Early buyers can still join the HYPER presale (https://bitcoinhyper.com/) at the current stage and start earning staking rewards immediately. The next price tier is approaching, which is why many investors are locking in positions before the increase. The presale has already crossed more than $27M, signaling strong demand and real momentum behind the project. Investors who stake HYPER early can capture higher yields and secure their allocation before the next stage moves up.

Buchenweg 15, Karlsruhe, Germany

For more information about Bitcoin Hyper (HYPER) visit the links below:

Website: https://bitcoinhyper.com/

Whitepaper: https://bitcoinhyper.com/assets/documents/whitepaper.pdf

Telegram: https://t.me/btchyperz

Twitter/X: https://x.com/BTC_Hyper2

Disclosure: Crypto is a high-risk asset class. This article is provided for informational purposes and does not constitute investment advice.

CryptoTimes24 is a digital media and analytics platform dedicated to providing timely, accurate, and insightful information about the cryptocurrency and blockchain industry. The enterprise focuses on delivering high-quality news coverage, market analysis, project reviews, and educational resources for both investors and enthusiasts. By combining data-driven journalism with expert commentary, CryptoTimes24 aims to become a trusted global source for emerging trends in decentralized finance (DeFi), NFTs, Web3 technologies, and digital asset markets.

This release was published on openPR.

Source link

19 11, 2025

Natural gas price keeps its bullish track– Forecast today – 19-11-2025

By |2025-11-19T12:34:29+02:00November 19, 2025|Forex News, News|0 Comments


Natural gas prices lost bullish momentum recently due to stochastic attempt to exit the overbought level, which forced it to provide mixed trading by its stability near $4.380.

 

Reminding you that the stability above the extra support at $4.200 forms a main factor to motivate the bullish track, to expect begin forming bullish trading, targeting $4.750 level and surpassing this barrier will form the next main target at $4.910 level in the near-term trading.

 

The expected trading range for today is between $4.200 and $4.700

 

Trend forecast: Bullish

 





Source link

19 11, 2025

British Pound to Dollar Forecast: GBP Coils Below 1.32

By |2025-11-19T12:19:32+02:00November 19, 2025|Forex News, News|0 Comments


– Written by

The Pound-to-Dollar exchange rate (GBP/USD) hovered around 1.3160 on Tuesday, holding a narrow range despite a sharp rise in global market volatility.

With equity markets sliding and safe-haven demand resurfacing, traders are braced for a breakout from the tight band that has contained the pair so far this week.

GBP/USD Forecasts: Poised for a Breakout

Although there has been a wider increase in volatility, the Pound to Dollar rate has been held in relatively narrow ranges and settled little changed around 1.3160.

On a near-term view, UOB commented; “Today, we continue to expect GBP to trade in a range, most likely between 1.3125 and 1.3185.”

Narrow ranges, however, are unlikely to persist given wider market conditions.

ING has a year-end GBP/USD forecast of 1.34.

Save on Your GBP/USD Transfer

Get better rates and lower fees on your next international money transfer.
Compare TorFX with top UK banks in seconds and see how much you could save.


Compare the Best GBP/USD Rates »

The Pound has been hurt by a slide in risk appetite with another round of significant FTSE 100 index losses on Tuesday. Weaker risk conditions tend to hurt the Pound and benefit the dollar, but there is uncertainty whether the dollar can benefit this time, especially if the focus is on US tech stocks.

ING commented; “The risk-off environment at the start of the week is prompting a return of safe-haven demand for the dollar. While valuation concerns ahead of tomorrow’s Nvidia earnings release appear to be a key driver of the equity sell-off, the move has been global – not confined to US markets.”

It added; “That’s what matters most for FX: as long as the sell-off is broad-based, the dollar can benefit from safe-haven flows.”

Federal Reserve policy will also be a key element with markets pricing in just under a 50% chance of a Fed rate cut at the December 10th meeting.

Overnight, Fed Governor Waller called for a further cut in December with fellow Governor Jefferson also suggesting he would back a cut, but other committee members will oppose a move.

Traders will be wary over the potential for guidance and labour-market data this week could be pivotal.

Danske Bank commented; “It is relatively rare for a Fed decision to remain a coin flip this close to the meeting; if the data fail to provide sufficient guidance, Powell and other Fed officials may step in with clearer communication to avoid entering the blackout period without a defined market stance.”

It also noted multiple forces on the dollar but added; “Nevertheless, we expect the USD to end the year stronger if the Fed does not cut in December, despite the recent disconnect between front-end yields and the greenback.”

MUFG noted dovish Fed talk and added; “As a result, we are sticking to our call for another Fed cut in December unless evidence emerges of a strong pick-up in labour demand in the month ahead. It remains a key assumption behind our forecasts for a weaker US dollar.”

Like this piece? Please share with your friends and colleagues:




International Money Transfer? Ask our resident FX expert a money transfer question or try John’s new, free, no-obligation personal service! ,where he helps every step of the way,
ensuring you get the best exchange rates on your currency requirements.

TAGS: Pound Dollar Forecasts

Source link

19 11, 2025

Nutraceuticals Market to Hit USD 1,128 Billion by 2032 as

By |2025-11-19T12:04:28+02:00November 19, 2025|Dietary Supplements News, News|0 Comments


The global Nutraceuticals Market is entering a defining growth phase as consumers worldwide continue shifting toward preventive healthcare, clean-label nutrition, and functional wellness solutions. With increased emphasis on immunity, digestive health, metabolic support, and lifestyle-driven nutrition, nutraceuticals have evolved into a mainstream component of daily dietary habits. According to the latest industry assessment, the market is projected to rise from USD 702 billion in 2025 to USD 1,128 billion by 2032, expanding at a CAGR of 7.0%. The expansion is shaped by advances in functional food formulation, rapid innovation in dietary supplements, growing retail penetration, and rising consumer willingness to invest in premium wellness products.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response):

https://www.fairfieldmarketresearch.com/report/nutraceuticals-market/request-sample

Market Insights

Global demand for nutraceuticals continues to accelerate as health awareness intensifies across all demographics. Functional foods remain widely preferred for their convenience and nutritional value, while dietary supplements continue gaining traction thanks to expanding clinical validation and broader product availability. The rise of personalized nutrition and microbiome-focused wellness is reshaping product development trends, encouraging manufacturers to integrate science-backed ingredients such as botanicals, omega fatty acids, amino acids, fibers, and specialty carbohydrates. Additionally, the expanding presence of online distribution channels is enabling faster reach, competitive pricing, and easy accessibility to a diverse product portfolio. As consumers prioritize long-term wellbeing, nutraceutical brands are adopting transparent labeling, sustainable sourcing, and enhanced traceability to build trust and differentiate in an increasingly competitive landscape.

Explore the Full Report:

https://www.fairfieldmarketresearch.com/report/nutraceuticals-market

Drivers

Growing interest in preventive healthcare is the primary driver fueling nutraceutical adoption, with consumers proactively seeking products that address chronic lifestyle conditions, boost immunity, and support overall vitality. The global rise in lifestyle-related disorders, including obesity, cardiovascular conditions, and diabetes, is further accelerating product demand. Evolving dietary habits, urbanization, increasing disposable incomes, and heightened fitness awareness collectively contribute to consistent market expansion. Regulatory encouragement through structured guidelines for safety, quality, and fortification also supports industry growth. The addition of clean-label, plant-based, and organic formulations is attracting health-conscious consumers, while technological advancements in extraction, encapsulation, and fermentation techniques enhance ingredient stability and efficacy.

Business Opportunity

Significant business opportunities exist across product innovation, digital retail expansion, and specialty nutrition categories. Companies focusing on targeted nutritional solutions-such as probiotic-infused foods, protein-rich supplements, botanical blends, and metabolic health enhancers-are poised for strong growth. Partnerships between research organizations and nutraceutical manufacturers are enabling faster commercialization of science-backed ingredients with clinically validated benefits. Brands leveraging e-commerce, subscription-based nutrition boxes, AI-driven diet personalization, and direct-to-consumer wellness platforms are expanding market penetration. Furthermore, emerging markets across Asia, Latin America, and the Middle East offer high-growth potential due to rising health consciousness and expanding middle-class populations. Sustainable packaging, transparency initiatives, and ethical sourcing present added opportunities for differentiation.

Region Analysis

North America continues to hold a strong position driven by established healthcare awareness, high purchasing power, and widespread adoption of functional foods and supplements. The region benefits from advanced product innovation and strong regulatory frameworks supporting product quality. Europe exhibits sustained demand for natural ingredients, botanical extracts, and clean-label offerings, supported by strict nutritional guidelines and well-informed consumers. Asia Pacific is the fastest-expanding regional landscape, driven by rapid urbanization, rising disposable incomes, and growing acceptance of functional wellness products. Countries such as China, India, Japan, and South Korea are witnessing significant growth in supplement consumption, fortified foods, and herbal nutrition. Latin America is gaining momentum as consumers increasingly prioritize immune health and metabolic wellness. Meanwhile, the Middle East & Africa presents growing opportunities with rising retail penetration, expanding healthcare infrastructure, and increasing awareness of lifestyle nutrition.

Key Players

Major companies shaping the global nutraceuticals landscape include:

• BASF Corporation

• Cargill Inc

• DSM

• Lonza

• Corbion

• Ingredion Incorporated

• Archer-Daniels-Midland Company

• Friesland Campina

• Kerry PLC

• Olam International Ltd.

Contact US:

Fairfield Market Research

G04 Golden Mile House, Clayponds Lane, Brentford, London TW8 0GU

Office:+44 (0) 203 892 0037

Mobile:+44 (0) 7538 426 479

Email: sales@fairfieldmarketresearch.com

Web:www.fairfieldmarketresearch.com

About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

This release was published on openPR.



Source link

19 11, 2025

XRP Price Prediction: The Critical Period that Determines the Next Direction

By |2025-11-19T11:59:31+02:00November 19, 2025|Crypto News, News|0 Comments

Jakarta, Pintu News – Ripple is currently at a tipping point, with the price trying to stabilize in an important technical zone after several weeks of controlled declines. The token is trading at around $2.16, where it continues to test the 0.382 Fibonacci region. This level has become an important reference point for traders watching the next move of the decision, as the market structure weakens and momentum slows down.

Downward Trend Persistence

XRP continues to follow a clear pattern of lower highs and lower lows on the 4-hour chart. The price is below the 9 EMA and below the Supertrend, which signals continued selling pressure. This suggests that there is still a dominant selling force in the market, which could affect the next price movement.

Source: Coinedition

Open interest for XRP futures has risen sharply throughout 2025. Open interest grew from under $1 billion in early October to a peak of over $6 billion as volatility increased. The leveraged positions returning to the market indicate significant strength, which could influence future price dynamics.

Read also: 10 Layer-1 Crypto that Potentially Reach ATH in 2026

Inflow and Outflow Data Shows Weak Accumulation

The capital flow data shows consistent outputs throughout 2025. Outflows between $30 million and $150 million appear frequently, indicating continued distribution by large holders. This could be an indicator that there is a tendency to sell rather than buy among large holders, which could affect price stability.

XRP Price Prediction: The Critical Period that Determines the Next Direction
Source: Coinedition

XRP’s near-term outlook depends on whether buyers can hold the $2.16-$2.17 support zone long enough to build momentum towards the $2.25-$2.33 region. Technical compression and increasing leverage both suggest that high volatility is likely in the upcoming sessions.

FAQ

What makes the Ripple XRP (XRP) price in the critical phase in November 2025?

The XRP price is hovering around $2.16 and continues to test the Fibonacci level of 0.382, which became an important technical area after several weeks of decline. This level determines whether the trend structure can hold or weaken further.

Who is dominating XRP’s current market activity?

Selling pressure is still dominant, reflected in the price position below EMA 9 and Supertrend. Distribution by large holders throughout 2025 also reinforces the pressure.

When does the increase in XRP open interest occur throughout 2025?

Open interest increased from early October 2025, growing from under $1 billion to over $6 billion by November. This rise coincided with increased volatility in the market.

Where are XRP’s key support zones that market participants are watching?

The critical support zone is in the $2.16-$2.17 range, which is the focus in determining whether prices can maintain short-term stability.

Why do capital flows show a distribution in 2025?

Outflows between $30 million and $150 million indicate a sell-off by large holders during 2025. This indicates weak accumulation and consequent price pressure.

That’s the latest information about crypto. Follow us on Google News to get the latest crypto news about crypto projects and blockchain technology. Also, learn crypto from scratch with complete discussion through Pintu Academy and stay up-to-date with the latest crypto market such as bitcoin price today, xrp coin price today, dogecoin and other crypto asset prices through Pintu Market.

Enjoy an easy and secure crypto trading experience by downloading Pintu crypto app through Google Play Store or App Store now. Also, get a web trading experience with various advanced trading tools such as pro charting, various types of order types, and portfolio tracker only at Pintu Pro.


*Disclaimer

This content aims to enrich readers’ information. Pintu collects this information from various relevant sources and is not influenced by outside parties. Note that an asset’s past performance does not determine its projected future performance. Trading crypto carries high risk and volatility, always do your own research and use cold hard cash before investing. All activities of buying and selling bitcoin and other crypto asset investments are the responsibility of the reader.

Reference

Source link

19 11, 2025

Herbal Management of Diabetes – Women Fitness

By |2025-11-19T11:39:26+02:00November 19, 2025|Fitness News, News|0 Comments


Many studies have been performed on various naturally occurring herbs and other compounds, demonstrating their ability to lower blood sugars.

 

While many of these compounds decrease the blood glucose level by stimulating the pancreas to produce more insulin, one particular herb, Goat’s Rue or French Lilac, chemically known as guianidine, is particularly effective in reducing the blood glucose level utilizing a different mechanism.

Galega officinalis

(also known as Goat’s Rue, French Lilac, Italian Fitch or Professor-weed) is a plant from the Galega genus of the Faboideae.

Medical Use

Galega officinalis has been known since the Middle Ages for relieving the symptoms of diabetes mellitus. Upon analysis, it turned out to contain guanidine, a substance that decreases blood sugar by decreasing insulin resistance.

Chemical derivatives from the biguanide class of medication include metformin (Glucophage, commonly prescribed for diabetics) and the older, withdrawn agent phenformin.

This herb actually decreases the cellular resistance to insulin, allowing the cells to utilize the insulin more efficiently in metabolizing glucose. It also decreases the absorption of glucose from the small intestine. It reduces the formation of glucose in the liver, and it increases the uptake and utilization of glucose in the fat and muscle cells throughout the body. Non-insulin dependent diabetics are able to better maintain blood glucose levels closer to the normal range, while insulin dependent diabetics are often able to reduce their insulin dosage and more easily maintain stable levels of the blood glucose.

Ginseng

Ginseng refers to species within Panax, a genus of 11 species of slow-growing perennial plants with fleshy roots, in the family Araliaceae. They grow in the Northern Hemisphere in eastern Asia (mostly northern China, Korea, and eastern Siberia), typically in cooler climates.

Medical Use

Both American and Panax (Asian) ginseng rhizomes are taken orally as adaptogens, aphrodisiacs, nourishing stimulants, and in the treatment of type II diabetes, including sexual dysfunction in men. It appears that ginseng increases the sensitivity of cells to insulin, a hormone that sends the signal to cells to reduce blood sugar by taking up glucose. Ginseng may also increase the secretion of insulin.

In a randomized, placebo-controlled study published in the September issue of Diabetes Care, researchers gave capsules of North American ginseng (Panax quinquefolius) to diabetic subjects who were already receiving treatment for diabetes in the form of diet or prescription drugs. In their analysis, the researchers found that subjects receiving a 3g dose of ginseng had a blood sugar level that was 59.1% less than subjects who had received the placebo treatment.

Ginseng should be used therapeutically only with the advice of a trained health practitioner. Although subjects in the study did not report major side effects, ginseng can potentially augment the effect of prescription drugs used to lower blood sugar, causing a dangerous decrease in blood sugar. Adverse effects with concurrent use of oral anti-diabetic drugs, such as Warfarin, heparin, aspirin, and NSAIDS are another possibility.

Cinnamon

Herbal Management of Diabetes – Women Fitness

Cinnamon is the inner bark of a tropical evergreen tree. The two main varieties are Cinnamomum cassia and Cinnamomum zeylanicum.

Medical Use

American scientists have claimed that a teaspoon of cinnamon a day may help prevent the onset of diabetes. Scientists at the US Agricultural Research Services’ nutrition laboratories in Beltsville, Md., found that an extract of cinnamon can actually revitalize the body’s ability to be far more responsive to insulin in peripheral tissues, e.g. adipose and muscle tissue. In fact, in laboratory experiments, glucose processing was increased by up to 20 times. The chemical responsible is called methylhydroxy chalcone polymer. Experiments on mice found that abnormally high glucose concentrations fell dramatically when given this cinnamon derivative.

The results of another study from 2003 in Pakistan showed lower levels of fasting glucose, triglycerides, LDL cholesterol and total cholesterol after 40 days with levels continuing to drop for 20 days after that.

The study was made up of 60 people with Type 2 diabetes who were divided into 6 groups of 10. Three groups received cinnamon in the form of capsules totaling 1, 3 or 6 grams of cinnamon a day. The other three groups received placebo capsules. The capsules were taken three times a day, after meals. All three levels of cinnamon showed results, leading researchers to believe that as little as 1 gram a day of cinnamon may benefit people who have Type 2.

Type II diabetics should take a quarter to one full teaspoon of cinnamon per day.

Cinnamon has long been known as an “energizing” spice, and it is likely that increasing the intake of this common and cheaply available food will benefit even non-diabetics, if used as a daily energizing tonic.

Cinnamon is also a rich source of magnesium, which is essential for maintaining bone density, electrolyte balance, certain enzyme functions and many other crucial biochemical processes. Magnesium is also linked to the more dramatic forms of diabetes that occur earlier in life.

Bitter Melon

Momordica charantia is a tropical and subtropical vine of the family Cucurbitaceae, widely grown for edible fruit, which is among the most bitter of all vegetables. English names for the plant and its fruit include bitter melon or bitter gourd. It is widely grown in India (Karela करेला in Hindi), Pakistan (Karela کریلا in Urdu, اردو),(komboze کمبوزه in Persian), South Asia, Southeast Asia, China, Africa and the Caribbean.

Medical Use

Bitter melon has been observed to have blood sugar-lowering effects, but there is only limited research specifically using bitter melon in humans. Clinical studies show that bitter melon increases the production of beta cells in the pancreas which leads to improvement in the insulin production of the body.

Many studies show that bitter melon is able to reduce the blood sugar levels in the body. Charantin, polypeptide P, and oleonolic acid glcosides are some of the ingredients of bitter melon that are essential in diabetes treatment. Charantin consists of mixtures of natural steroids which are shown to reduce blood sugar levels in the body. Polypeptide P, contains alkaloids that can also promote healthy blood sugar levels. Oleanolic acid glycosides, on the other hand, may prevent the retention of sugar from the intestines. Improvements in these area leads to improved insulin levels in the body.

Fresh juice of two karelas (approximately 20ml) should be taken on empty stomach in the early morning daily. The regular practice of this gives enormous benefits to the diabetics.

Herbal Management of Diabetes

Amla or Emblica Officinalis

It is a natural, efficacious, an antioxidant with the richest natural source ofVitamin C.

Medical Use

Amalaki is a carminative and stomachic. It is used in Ayurveda as a cardiotonic, aphrodisiac, antipyretic, antidiabetic, cerebral and gastrointestinal tonic. It raises the total protein level and increases the body weight due to positive nitrogen balance. It has been found to have an anabolic effect.

Fresh amla juice of 10ml and 2 grams pure haldi (turmeric) powder well mixed and taken twice a day, effectively maintains the sugar level and imparts many side benefits like strength and vitality.

Besides, this herb, due to its high vitamin C content, is effective in controlling diabetes. A tablespoon of its juice mixed with a cup of bitter gourd juice, taken daily for two months. Will stimulates the pancreas and enable is to secrete insulin, thus reducing the blood sugar in the diabetes. Diet restrictions should be strictly observed while taking this medicine. It will also prevent eye complication in diabetes.

Fenugreek (Trigonella foenum-graecum)

It is a plant product that has been used for a variety of medicinal and other purposes, and may be used in the treatment of diabetes. Fenugreek is a member of the Leguminosae, or Fabaceae, family and grows well in India, Egypt and other parts of the Middle East. The part used medicinally is the seeds.

Medical Use

Fenugreek seeds contain alkaloids, including trigonelline, gentianine and carpaine compounds. The seeds also contain fiber, 4-hydroxyisoleucine and fenugreekine, a component that may have hypoglycemic activity. The mechanism is thought to delay gastric emptying, slow carbohydrateabsorption and inhibit glucose transport.

Fenugreek may also increase the number of insulin receptors in red blood cells and improve glucose utilization in peripheral tissues, thus demonstrating potential anti-diabetes effects both in the pancreas and other sites. The amino acid 4- hydroxyisoleucine, contained in the seeds, may also directly stimulate insulin secretion.

There are only a few published studies on fenugreek. In one study, published in a 1990 issue of the European Journal of Clinical Nutrition, 10 patients on insulin therapy for type 1 diabetes were assigned to either placebo or 50 grams of defatted fenugreek-seed powder twice daily in addition to their insulin therapy.

Fasting glucose decreased from an average of 272 mg/dl at baseline to 196 mg/dl. There was also a decrease in total cholesterol, LDL (“bad”) cholesterol and triglycerides.

A larger study, published in a 1996 issue of Nutrition Research, involved a six-month trial of fenugreek in 60 patients with inadequately controlled type 2 diabetes. Twenty-five grams of powdered fenugreek seed was given twice daily at lunch and dinner in addition to the current diabetes therapy.

The average fasting glucose decreased from 151 mg/dl to 112 mg/dl after 6 months. Glucose values one and two hours after meals also declined. Average A1C decreased from 9.6% to 8.4% after eight weeks. To help your diabetes symptoms, try taking 2.5 g of fenugreek with your meals, a couple of times a day. This should help to control your blood sugar levels and increase your insulin production.

 Black Berry (kala jamun)

Botanically it is known as Polianthes tuberosa. It is a large tree 20 to 60 ft. high or sometimes more. The bark, fruits and seeds of the tree are medicinal. The bark is very astringent and is given in sore throat, bronchitis, asthma, ulcers and dysentery; it is also used for purifying blood. The fresh juice of the bark with goat’s milk is given in diarrhoea. The seeds are very useful diabetes. The fruit juice cures burning sensation of hands and feet. It subsides excessive heat in the body.

Medical Use

To control diabetes, 2-teaspoon powder of dry jambul fruits is taken twice a day or eating of fresh jumbul fruits is also recommended. Three to five grams of powdered seed with salt taken twice a day for a few days eliminates sugar.

A regular check should be kept on the blood sugar level, and if it settles in the normal range, no further treatment is needed.

 

Disclaimer
The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.



Source link

Go to Top